Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP2 | P50579 | 2/20 | 0.96 |
| ▸ | PLAU | P00749 | 1/20 | 0.57 |
| ▸ | NCF1 | P14598 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 4/20 | 0.56 |
| ▸ | CCR1 | P32246 | 1/20 | 0.56 |
| ▸ | CCR5 | P51681 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.55 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.55 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | PARP1 | P09874 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.52 |
| ▸ | SOS2 | Q07890 | 1/20 | 0.52 |
| ▸ | MMP2 | P08253 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 8-Hydroxy Quinaldine SCHEMBL28531654 | 1.00 | METAP2 (0.96) | METAP2PLAUNCF1RAB9ACCR1 | |
| 8-Hydroxy Quinaldine SCHEMBL297247 | 0.98 | METAP2 (1.00) | METAP2PLAUNCF1RAB9ACCR1 | |
| 8-Hydroxy Quinaldine SCHEMBL29483489 | 0.98 | METAP2 (1.00) | METAP2PLAUNCF1RAB9ACCR1 | |
| 8-Hydroxy Quinaldine SCHEMBL7179747 | 0.96 | METAP2 (0.96) | METAP2PLAUNCF1RAB9ACCR1 | |
| 8-Hydroxy Quinaldine SCHEMBL5089361 | 0.96 | METAP2 (0.96) | METAP2PLAUNCF1RAB9ACCR1 | |
| 8-Hydroxy Quinaldine SCHEMBL4762935 | 0.96 | METAP2 (0.96) | METAP2PLAUNCF1RAB9ACCR1 | |
| 8-Hydroxy Quinaldine SCHEMBL4304584 | 0.96 | METAP2 (0.96) | METAP2PLAUNCF1RAB9ACCR1 | |
| 8-Hydroxy Quinaldine SCHEMBL22734876 | 0.96 | METAP2 (0.96) | METAP2PLAUNCF1RAB9ACCR1 | |
| 8-Hydroxy Quinaldine SCHEMBL4401768 | 0.96 | METAP2 (0.96) | METAP2PLAUNCF1RAB9ACCR1 | |
| 8-Hydroxy Quinaldine SCHEMBL9154369 | 0.96 | METAP2 (0.96) | METAP2PLAUNCF1RAB9ACCR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7514158-B2 | Coumarin compound | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 2009-04-07 | — | — | US | disclosed |
| US-7504163-B2 | Hole-trapping materials for improved OLED efficiency | EASTMAN KODAK COMPANY (US) | 2009-03-17 | — | — | US | disclosed |
| US-20070126347-A1 | OLEDS with improved efficiency | EASTMAN KODAK COMPANY | 2007-06-07 | — | — | US | disclosed |
| US-20070018568-A1 | Organic electroluminescent device | KABUSHIKI KAISHA TOYOTA JIDOSHOKKI (JP) | 2007-01-25 | — | — | US | disclosed |
| US-20060228577-A1 | Organic electroluminescent device | KABUSHIKI KAISHA TOYOTA JIDOSHOKKI (JP) | 2006-10-12 | — | — | US | disclosed |
| US-20060008672-A1 | Hole-trapping materials for improved OLED efficiency | EASTMAN KODAK COMPANY | 2006-01-12 | — | — | US | disclosed |
| US-20050275341-A1 | Coumarin compound | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 2005-12-15 | — | — | US | disclosed |
| EP-1599074-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | Kabushiki Kaisha Toyota Jidoshokki (JP) | 2005-11-23 | — | — | EP | disclosed |
| EP-1560469-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | Kabushiki Kaisha Toyota Jidoshokki (JP) | 2005-08-03 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050275341-A1 | Coumarin compound | XPO1, VKORC1, XPO5 | METAP2 2661/4885PLAU 1222/4885NCF1 1366/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.